Barry P Flannelly Incyte Corp (INCY) insider trading activity

Barry P Flannelly is EVP & General Manager US of INCYTE CORP. Currently has a direct ownership of 35,149 shares of INCY, which is worth approximately $2.87 Million. The most recent transaction as insider was on Jul 02, 2022, when has been sold 13,529 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35.1K

41.13% 3M change

39.44% 12M change

Total Value Held $2.87 Million

Barry P Flannelly Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 02 2022	BUY Grant, award, or other acquisition	-	13,529 Added 14.61%	79,053 Common Stock
Apr 08 2022	SELL Open market or private sale	$3,661,538 $83.23 p/Share	43,993 Reduced 40.3%	65,163 Common Stock
Apr 08 2022	BUY Exercise of conversion of derivative security	$2,949,319 $70.45 p/Share	41,864 Added 32.08%	88,640 Common Stock
Jan 01 2022	BUY Grant, award, or other acquisition	-	8,678 Added 11.42%	67,292 Common Stock
Nov 19 2021	BUY Grant, award, or other acquisition	-	2,734 Added 4.46%	58,614 Common Stock
Jul 06 2021	SELL Payment of exercise price or tax liability	$22,752 $83.34 p/Share	273 Reduced 0.49%	55,880 Common Stock
Jul 02 2021	SELL Payment of exercise price or tax liability	$166,324 $83.58 p/Share	1,990 Reduced 3.42%	56,153 Common Stock
Jul 02 2021	BUY Grant, award, or other acquisition	-	7,853 Added 11.9%	58,143 Common Stock
Jan 25 2021	SELL Open market or private sale	$274,400 $100.0 p/Share	2,744 Reduced 5.2%	49,994 Common Stock
Jan 15 2021	BUY Grant, award, or other acquisition	-	11,522 Added 17.93%	52,738 Common Stock
Nov 16 2020	BUY Grant, award, or other acquisition	-	1,232 Added 2.9%	41,216 Common Stock
Nov 02 2020	SELL Open market or private sale	$1,732,000 $86.6 p/Share	20,000 Reduced 33.34%	39,984 Common Stock
Nov 02 2020	BUY Exercise of conversion of derivative security	$968,800 $48.44 p/Share	20,000 Added 25.01%	59,984 Common Stock

Also insider at

TARA

Protara Therapeutics, Inc. Healthcare

BPF